亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯(lián)系方式|購物車
企業(yè)會員第1年

湖北圣寶萊生物科技有限公司  

沒有填寫主營業(yè)務~~

搜索
新聞中心
  • 暫無新聞
產品分類
聯(lián)系方式
  • 聯(lián)系人:張誠
  • 電話:027-84231485
  • QQ:2279141009
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > CAS :80474-14-2 氟替卡松丙酸酯
CAS :80474-14-2 氟替卡松丙酸酯
單價 12600.00 / KG對比
銷量 暫無
發(fā)貨 湖北武漢市付款后3天內
庫存 1KG起訂1KG
型號 80474-14-2
規(guī)格 1kg/桶
過期 長期有效
更新 2013-07-02 15:39
 
詳細信息
氟替卡松丙酸酯
英文名稱: Fluticasone propionate
CAS NO:80474-14-2
分子式/結構式:C25H31F3O5S
分子量:500.571
產品規(guī)格:USP31
儲存方法: 室溫保存,避光、熱;保持良好通風干燥處密封保存;避免接觸眼睛、皮膚、衣物
溶解性: 可溶于二甲基亞砜:溶解度≥10mg/mL(常溫下)
外觀: 白色結晶
總雜:≤1.0% 含量:97.0%-102.0% 包裝:1KG/鋁聽或5kg/鋁聽功效:消炎。為局部有效的皮質甾體藥物。用于抗過敏反應。一種吸入性皮質類固醇激素,用于治療≥4 歲人群的季節(jié)性過敏性鼻炎和常年性過敏性鼻炎,哮喘及非過敏性鼻炎。
©2025 湖北圣寶萊生物科技有限公司 版權所有   技術支持:化工網   訪問量:5224  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |